Clinical Trials in Colorado

Showing 9601-9620 of 13,761 trials

Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease

NCT02013791

This study will evaluate a new ophthalmic formulation of cyclosporine (Restasis® X) in patients with moderate to severe dry eye disease in two stages. Up to 3 doses will be studied in Stage 2 based on results from Stage 1. No patients participating in Stage 1 will participate in Stage 2 of this study. This study was terminated and Stage 2 of the study was cancelled.

Dry Eye Syndromes

Allergan55 participantsStarted Apr 2014

Artesia, California, United States • Glendale, California, United States • Irvine, California, United States +5 more locations

COMPLETEDPhase 250 miles

A Phase IIa Study to Investigate the Efficacy and Safety of AZD7624 in Chronic Obstructive Pulmonary Disease (COPD) Patients While on Maintenance Therapy

NCT02238483

The purpose of this study is to determine whether AZD7624 can reduce acute Chronic Obstructive Pulmonary Disease (COPD) exacerbations in patients on COPD maintenance therapy with a history of frequent acute exacerbations.

Chronic Obstructive Pulmonary Disease COPD

AstraZeneca213 participantsStarted Oct 2014

Los Angeles, California, United States • Torrance, California, United States • Denver, Colorado, United States +38 more locations

Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease

A Phase IIa Study to Investigate the Efficacy and Safety of AZD7624 in Chronic Obstructive Pulmonary Disease (COPD) Patients While on Maintenance Therapy

Find Trials by Condition in Colorado

Phase 1 and 2 Study of PX-866 and Cetuximab

Evaluation of Potential Allergenicity of New Wheat Varieties

A Study of the Safety and Pharmacokinetics of RO6839921, An MDM2 Antagonist, in Patients With Advanced Cancers, Including Acute Myeloid Leukemia.

Phase 1 Study of ONT-10 in Patients With Solid Tumors

Phase I Trial of Oral PX-866

Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy

Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia

PF-00489791 For The Treatment Of Raynaud's

Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Study to Assess Functionality, Reliability, and Performance of a Pre-filled Syringe With Benralizumab Administered at Home

DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis

Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections

Behavioral & Nutritional Treatment to Help CF Preschoolers Grow

Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment

Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers

Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System

The Impact of Vitamin D on Disease Activity in Crohn's Disease

Prospective Multicenter Registry On RadiaTion Dose Estimates Of Cardiac CT AngIOgraphy IN Daily Practice in 2017